Intersect ENT, the sinus implant maker Medtronic bought for $1.1 billion in 2022, has recommitted to its entire 50,373-square-foot building at Tarlton Properties' 1555 Adams Drive in Menlo Park, keeping a key medical device manufacturing operation in place even as the San Francisco Peninsula's R&D vacancy climbed to 25.5 percent.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Rox, the General Catalyst- and Sequoia-backed developer of AI agents for sales...
ByThe RegistryNovember 22, 2026CBRE's third-quarter figures show the East Bay's industrial vacancy is concentrated in...
ByThe RegistryNovember 22, 2026Silicon Valley's third-quarter 2026 office leasing split in two, with renewals by...
ByThe RegistryNovember 22, 2026The San Francisco Peninsula's industrial market posted its first quarter of positive...
ByThe RegistryNovember 22, 2026